Brief: Molecure To Regain Worldwide Rights To Dual Chitinase Inhibitor Oatd-01
23/06/2022 21:58
June 23 (Reuters) - Molecure SA MOCP.WA :
* MOLECURE TO REGAIN WORLDWIDE RIGHTS TO DUAL CHITINASE
INHIBITOR
OATD-01
* MOLECURE SA - MOLECURE TO REGAIN ALL RIGHTS, ASSOCIATED
DATA, IP
AND INVENTORY TO OATD-01
* MOLECURE SA - EVALUATING POTENTIAL FIRST INDICATION AND
DEVELOPMENT PLAN FOR ASSET IN SARCOIDOSIS
Source text for Eikon: ID:nPreq1qHka
Further company coverage: MOCP.WA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Molecure SA
See all newsBrief: Molecure Q1 Net Loss 4.1 Mln Zlotys
Brief: Molecure Says Its In-Consortium Project Selected For Funding By Medical Research Agency
Brief: Molecure To Sell 4.12 Mln Series K Shares and 2.0 Mln Existing Shares At 5 Zlotys/Shr
Brief: Molecure Starts ABB For Up to 4.12 Mln New Series K Shares And Up To 2.0 Mln Existing Shares
Brief: Molecure Signs Conditional Investment Agreement With MS Galleon And Szumowski Investments